Among the companies with shares expected to actively trade in
Monday's session are Health Management Associates Inc. (HMA),
Mannkind Corp. (MNKD) and Zoltek Cos. (ZOLT).
Health Management's second-quarter profit fell 80% as its
same-hospital revenue declined and expenses mounted, news that
comes as the battle for its board heats up and after the company
agreed to sell itself to a rival hospital operator. Shares slipped
2% to $12.97 after hours.
Mannkind reported a wider-than-expected loss for the second
quarter. Shares of the biopharmaceutical company fell 1.6% to $7.36
after hours.
Zoltek, which makes carbon fibers that strengthen and lighten
materials, reported a drop in revenue for its fiscal third quarter
as the company's chief executive said "the cyclical downturn in the
wind energy market, which began in the fourth quarter of fiscal
2012, continued to negatively affect our sales and operating
results in the third quarter." Shares fell 3.4% to $13.29 after
hours.
Watchlist:
Standard & Poor's Ratings Services lowered its rating on
Cytec Industries Inc. (CYT) to the brink of junk territory, noting
the business risk for the company's aerospace-materials segment is
weaker than previously estimated.
The U.S. International Trade Commission on Friday ordered a ban
on the import and sale of some Samsung Electronics Co. (SSNHZ,
005930.SE) mobile devices after finding they infringed two Apple
Inc. (AAPL) patents.
Standard & Poor's Ratings Services raised its ratings on
Spectrum Brands Holdings Inc. (SPB), citing the consumer-products
company's plan to refinance debt and a recent acquisition that
looks favorable.
Write to Nathalie Tadena at nathalie.tadena@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires